BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23151828)

  • 21. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls.
    Johnson PT; Horton KM; Fishman EK
    Radiographics; 2009; 29(5):1333-51. PubMed ID: 19755599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of adrenal tumors in patients with hepatocellular carcinoma: adrenal adenoma versus metastasis.
    Yasaka K; Gonoi W; Akai H; Katsura M; Akahane M; Kiryu S; Ohtomo K
    Eur J Radiol; 2013 Aug; 82(8):1213-8. PubMed ID: 23478006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transhepatic CT-guided radiofrequency ablation of adrenal metastases from hepatocellular carcinoma.
    Kuehl H; Stattaus J; Forsting M; Antoch G
    Cardiovasc Intervent Radiol; 2008; 31(6):1210-4. PubMed ID: 18584241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
    Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
    Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases.
    Foti G; Malleo G; Faccioli N; Guerriero A; Furlani L; Carbognin G
    Radiol Med; 2018 Nov; 123(11):833-840. PubMed ID: 29923085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adrenal tumors associated with renal cell carcinoma].
    Ebina T; Umemura S; Sugimoto K; Minamisawa K; Miyajima E; Shionoiri H; Tochikubo O; Takeda M; Ishii M
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):841-7. PubMed ID: 2273601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
    Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
    BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT sensitivity for adrenal adenoma according to lesion size.
    Park SY; Park BK; Park JJ; Kim CK
    Abdom Imaging; 2015 Oct; 40(8):3152-60. PubMed ID: 26254908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Takeuchi M; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2016 Nov; 207(5):1031-1038. PubMed ID: 27556736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.
    Schieda N; Krishna S; McInnes MDF; Moosavi B; Alrashed A; Moreland R; Siegelman ES
    AJR Am J Roentgenol; 2017 Sep; 209(3):W152-W159. PubMed ID: 28742373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodine and Fat Quantification for Differentiation of Adrenal Gland Adenomas From Metastases Using Third-Generation Dual-Source Dual-Energy Computed Tomography.
    Martin SS; Weidinger S; Czwikla R; Kaltenbach B; Albrecht MH; Lenga L; Vogl TJ; Wichmann JL
    Invest Radiol; 2018 Mar; 53(3):173-178. PubMed ID: 28990974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of delayed enhanced CT and 18F-FDG PET/CT in the evaluation of adrenal masses in oncology patients.
    Park BK; Kim CK; Kim B; Choi JY
    J Comput Assist Tomogr; 2007; 31(4):550-6. PubMed ID: 17882030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
    Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.
    Kang TW; Kim SH; Lee J; Kim AY; Jang KM; Choi D; Kim MJ
    Eur J Radiol; 2015 Nov; 84(11):2089-96. PubMed ID: 26318820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT time-attenuation washout curves of adrenal adenomas and nonadenomas.
    Korobkin M; Brodeur FJ; Francis IR; Quint LE; Dunnick NR; Londy F
    AJR Am J Roentgenol; 1998 Mar; 170(3):747-52. PubMed ID: 9490968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidental adrenal lesions: Accuracy of quadriphasic contrast enhanced computed tomography in distinguishing adenomas from nonadenomas.
    Foti G; Faccioli N; Mantovani W; Malleo G; Manfredi R; Mucelli RP
    Eur J Radiol; 2012 Aug; 81(8):1742-50. PubMed ID: 21602008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
    Hindman NM; Bosniak MA; Rosenkrantz AB; Lee-Felker S; Melamed J
    AJR Am J Roentgenol; 2012 Jan; 198(1):W20-6. PubMed ID: 22194510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Value of Nonenhanced Single-Source Dual-Energy CT for Differentiating Metastases From Adenoma in Adrenal Glands.
    Ju Y; Liu A; Dong Y; Liu Y; Wang H; Sun M; Pu R; Chen A
    Acad Radiol; 2015 Jul; 22(7):834-9. PubMed ID: 25957502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma.
    Blake MA; Krishnamoorthy SK; Boland GW; Sweeney AT; Pitman MB; Harisinghani M; Mueller PR; Hahn PF
    AJR Am J Roentgenol; 2003 Dec; 181(6):1663-8. PubMed ID: 14627592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.